SCHEMBL7525366

SCHEMBL7525366

OOOOOOOOO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7520281 1.00
SCHEMBL18950143 1.00
SCHEMBL7519506 1.00
SCHEMBL12678154 1.00
SCHEMBL12122527 1.00
SCHEMBL14571487 1.00
SCHEMBL13742846 1.00
SCHEMBL12143366 1.00
SCHEMBL13275075 1.00
SCHEMBL13322950 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230136073-A1 NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF FUJIFILM CORPORATION (JP) 2023-05-04 US disclosed
US-20180044376-A1 Method for Preparing Largazole Analogs and Uses Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-02-15 US disclosed
US-20170357325-A1 Localized Deflection Using a Bending Haptic Actuator APPLE INC. 2017-12-14 US disclosed
US-9783522-B2 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-10-10 US disclosed
US-20170283393-A1 Bruton's Tyrosine Kinase Inhibitors PFIZER INC. (US) 2017-10-05 US disclosed
US-9663725-B2 Catalytic compositions useful in removal of sulfur compounds from gaseous hydrocarbons, processes for making these and uses thereof SAUDI ARABIAN OIL COMPANY (SA) 2017-05-30 US disclosed
EP-2832373-B1 Liposome for blocking site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis EXPERIMENTELLE PHARMAKOLOGIE & ONKOLOGIE BERLIN BUCH (DE) 2017-04-12 EP disclosed
US-20170044133-A1 NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2017-02-16 US disclosed
US-9562244-B2 Method of producing plant suspension cells in a growth medium enriched with carbonic acid NATURALLY SCIENTIFIC TECHNOLOGIES LIMITED (GB) 2017-02-07 US disclosed
US-9469804-B2 Foaming composition with wettability modifying and corrosion inhibitory properties for high temperature and ultra-high salinity Instituto Mexico del Petroleo (MX) 2016-10-18 US disclosed
US-7425749-B2 MEMS pixel sensor SHARP LABORATORIES OF AMERICA, INC. (US) 2008-09-16 US disclosed
US-20080200445-A1 Use in treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, inhibitors of Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes; 4-imidazolidinone, 5-(3'-chloro[1,1'-biphenyl]-3-yl)-5-cyclopropyl-2-imino-3-(2,2,2-trifluoroethyl)-, for example SCHERING CORPORATION & PHARMACOPEIA DRUG DISCOVERY, INC. 2008-08-21 US disclosed
EP-1918382-A1 Semi-continuous cascade fermentation process for pantothenate production DSMIP Assets B.V. (NL) 2008-05-07 EP disclosed
US-20070287233-A1 Piezo-TFT cantilever MEMS fabrication SHARP LABORATORIES OF AMERICA, INC. 2007-12-13 US disclosed
EP-1855327-A2 Semiconductor light emitting device and method for manufacturing the same LG ELECTRONICS INC. (KR) 2007-11-14 EP disclosed
US-7253290-B2 3-[2,2-dimethyl-3-oxo-3-(7-azabicyclo[2.2.1]heptan-7-yl)propoxy]-4-[(1S)-1-methyl-2-[(isopropoxycarbonyl)imino(-3-pyridin-4-yl-pyrrolidin-1-yl)methyl]aminoethyl]-5-(3,5-dimethylphenyl)-1H-pyrazole; prodrugs for treating prostatic cancer, uterine cancer, breast cancer and pituitary gonadotrophe adenoma ASTRAZENECA AB (SE) 2007-08-07 US disclosed
US-20070161581-A1 Novel aminoglycoside antibiotics effective against methicillin resistant staphylococcus auerus (mrsas) MEIJI SEIKA KAISHA, LTD. (JP) 2007-07-12 US disclosed
US-20070072852-A1 2-(Imino-),3,6-(dimethyl-),4-(oxo=),6-(3-(methoxy-)phenyl)-(1,4-phenylene)-perhydropyrimidine; aspartyl protease inhibitors; cardiovascular diseases; cognition activators; neurodegenerative diseases; viricides; HIV; enzyme inhibitors of plasmepins, cathepsin D and protozoal enzymes; hypotensive agents SCHERING CORPORATION 2007-03-29 US disclosed
US-20070065499-A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof GEORGETOWN UNIVERSITY (US) 2007-03-22 US disclosed
US-20070023851-A1 MEMS pixel sensor SHARP KABUSHIKI KAISHA (JP) 2007-02-01 US disclosed